{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:10:12Z","timestamp":1784826612351,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.trim.2023.101906","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T19:46:46Z","timestamp":1690228006000},"page":"101906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A prospective validation of a population pharmacokinetic model of tacrolimus in Tunisian kidney transplant patients"],"prefix":"10.1016","volume":"80","author":[{"given":"Nadia","family":"Ben-Fredj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibtissem","family":"Hannachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Ben-Romdhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najah","family":"Ben-Fadhel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Chaabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohra","family":"Chadly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naceur","family":"Boughattas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Aouam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.trim.2023.101906_bb0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.trim.2023.101906_bb0010","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/petr.12369","article-title":"Tacrolimus therapeutic drug monitoring and pediatric renal transplant graft outcomes","volume":"18","author":"Larkins","year":"2014","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.trim.2023.101906_bb0015","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/tri.12155","article-title":"Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF genomics","volume":"26","author":"Israni","year":"2013","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2023.101906_bb0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0041-1345(98)01633-9","article-title":"Low systemic exposure to tacrolimus correlates with acute rejection","volume":"31","author":"Undre","year":"1999","journal-title":"Transplant. Proc."},{"issue":"4","key":"10.1016\/j.trim.2023.101906_bb0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00007890-199402270-00008","article-title":"FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects","volume":"57","author":"Backman","year":"1994","journal-title":"Transplantation."},{"issue":"3","key":"10.1016\/j.trim.2023.101906_bb0030","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2125.1999.00007.x","article-title":"Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients","volume":"48","author":"B\u00f6ttiger","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.trim.2023.101906_bb0035","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/FTD.0b013e3181a8f02a","article-title":"Trough tacrolimus concentrations in the first week after kidney transplantation are related to acute rejection","volume":"31","author":"Borobia","year":"2009","journal-title":"Ther. Drug Monit."},{"issue":"9","key":"10.1016\/j.trim.2023.101906_bb0040","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/ndt\/16.9.1905","article-title":"Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation","volume":"16","author":"Staatz","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2023.101906_bb0045","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2215\/CJN.03791106","article-title":"Therapeutic monitoring of calcineurin inhibitors for the nephrologist","volume":"2","author":"Schiff","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.trim.2023.101906_bb0050","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.trim.2013.04.003","article-title":"Tacrolimus therapeutic drug monitoring in Tunisian renal transplant recipients: effect of post-transplantation period","volume":"28","author":"Ben Fredj","year":"2013","journal-title":"Transpl. Immunol."},{"issue":"4","key":"10.1016\/j.trim.2023.101906_bb0055","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0041-1345(98)00234-6","article-title":"Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European tacrolimus multicentre renal study group","volume":"30","author":"Undre","year":"1998","journal-title":"Transplant. Proc."},{"issue":"3","key":"10.1016\/j.trim.2023.101906_bb0060","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/FTD.0b013e318285e779","article-title":"Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure","volume":"35","author":"Saint-Marcoux","year":"2013","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.trim.2023.101906_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/FTD.0b013e318198d092","article-title":"Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference","volume":"31","author":"Wallemacq","year":"2009","journal-title":"Ther. Drug Monit."},{"issue":"18","key":"10.1016\/j.trim.2023.101906_bb0070","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2217\/pgs.15.138","article-title":"Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase","volume":"16","author":"Aouam","year":"2015","journal-title":"Pharmacogenomics."},{"issue":"4","key":"10.1016\/j.trim.2023.101906_bb0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FTD.0b013e31825c4ba6","article-title":"Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R","volume":"34","author":"Neely","year":"2012","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.trim.2023.101906_bb0080","series-title":"Modeling of Tacrolimus Exposure in Kidney Transplant According to Post-transplant Time Based on Routine Trough Concentration Data","first-page":"394","volume":"4","author":"Ben Fredj","year":"2016"},{"issue":"8","key":"10.1016\/j.trim.2023.101906_bb0090","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s40262-016-0491-3","article-title":"A new CYP3A5*3 and CYP3A4*22 cluster influencing tacrolimus target concentrations: a population approach","volume":"56","author":"Andreu","year":"2017","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.trim.2023.101906_bb0095","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/tri.12194","article-title":"Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation","volume":"26","author":"Asberg","year":"2013","journal-title":"Transpl. Int."},{"issue":"10","key":"10.1016\/j.trim.2023.101906_bb0100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2165\/11535950-000000000-00000","article-title":"Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation","volume":"49","author":"Benkali","year":"2010","journal-title":"Clin. Pharmacokinet."},{"issue":"10","key":"10.1016\/j.trim.2023.101906_bb0105","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/TP.0000000000000708","article-title":"Improved tacrolimus target concentration achievement using computerized dosing in renal transplant recipients \u2013 a prospective, randomized study","volume":"99","author":"St\u00f8rset","year":"2015","journal-title":"Transplantation."},{"issue":"4","key":"10.1016\/j.trim.2023.101906_bb0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","article-title":"Some suggestions for measuring predictive performance","volume":"9","author":"Sheiner","year":"1981","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.trim.2023.101906_bb0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/096228029900800204","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.trim.2023.101906_bb0120","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1177\/0091270009333853","article-title":"Prospective evaluation of the Bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation","volume":"49","author":"Fukudo","year":"2009","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.trim.2023.101906_bb0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.curtheres.2006.04.005","article-title":"Estimation of minimum whole-blood tacrolimus concentration for therapeutic drug monitoring with plasma prednisolone concentration: a retrospective cohort study in Japanese kidney transplant recipients","volume":"67","author":"Sugioka","year":"2006","journal-title":"Curr. Ther. Res. Clin. Exp."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423001235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423001235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:04:40Z","timestamp":1760810680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327423001235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":24,"alternative-id":["S0966327423001235"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2023.101906","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prospective validation of a population pharmacokinetic model of tacrolimus in Tunisian kidney transplant patients","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2023.101906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101906"}}